Ebihara H - Search Results

1

Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement.

Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, Freeman WD, Radisky ES, Le Roch KG, Weisend CM, Ebihara H, Caulfield TR. Coban MA, et al. Among authors: ebihara h. Biomolecules. 2021 May 23;11(6):787. doi: 10.3390/biom11060787. Biomolecules. 2021. PMID: 34071060 Free PMC article.

2

The NF-κB inhibitor, SC75741, is a novel antiviral against emerging tick-borne bandaviruses.

Mendoza CA, Yamaoka S, Tsuda Y, Matsuno K, Weisend CM, Ebihara H. Mendoza CA, et al. Among authors: ebihara h. Antiviral Res. 2021 Jan;185:104993. doi: 10.1016/j.antiviral.2020.104993. Epub 2020 Dec 6. Antiviral Res. 2021. PMID: 33296695 Free PMC article.

3

Platforms for Personalized Polytherapeutics Discovery in COVID-19.

Hopkins C, Onweni C, Zambito V, Fairweather D, McCormick K, Ebihara H, Caulfield T, Zhang YS, Freeman WD. Hopkins C, et al. Among authors: ebihara h. J Mol Biol. 2021 May 14;433(10):166945. doi: 10.1016/j.jmb.2021.166945. Epub 2021 Mar 20. J Mol Biol. 2021. PMID: 33753053 Free PMC article. Review.

4

Inactivation of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on common surfaces by disinfectants.

Pope ZC, Weisend CM, Shah A, Ebihara H, Rizza SA. Pope ZC, et al. Among authors: ebihara h. Infect Control Hosp Epidemiol. 2023 Mar;44(3):504-506. doi: 10.1017/ice.2021.527. Epub 2022 Jan 26. Infect Control Hosp Epidemiol. 2023. PMID: 35078553 Free PMC article.

5

Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses.

Yamaoka S, Weisend CM, Swenson VA, Ebihara H. Yamaoka S, et al. Among authors: ebihara h. Antiviral Res. 2022 Apr;200:105291. doi: 10.1016/j.antiviral.2022.105291. Epub 2022 Mar 13. Antiviral Res. 2022. PMID: 35296419 Free PMC article.

6

Complete genome sequencing of mosquito and human isolates of Ngari virus.

Groseth A, Weisend C, Ebihara H. Groseth A, et al. Among authors: ebihara h. J Virol. 2012 Dec;86(24):13846-7. doi: 10.1128/JVI.02644-12. J Virol. 2012. PMID: 23166252 Free PMC article.

7

Identifying target cells for a tick-borne virus that causes fatal hemorrhagic fever.

Yamaoka S, Weisend C, Ebihara H. Yamaoka S, et al. Among authors: ebihara h. J Clin Invest. 2020 Feb 3;130(2):598-600. doi: 10.1172/JCI134512. J Clin Invest. 2020. PMID: 31904585 Free PMC article.

8

Complete genome sequence of trivittatus virus.

Groseth A, Vine V, Weisend C, Ebihara H. Groseth A, et al. Among authors: ebihara h. Arch Virol. 2015 Oct;160(10):2637-9. doi: 10.1007/s00705-015-2532-x. Epub 2015 Jul 28. Arch Virol. 2015. PMID: 26212363 Free PMC article.

9

An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.

Tsuda Y, Hoenen T, Banadyga L, Weisend C, Ricklefs SM, Porcella SF, Ebihara H. Tsuda Y, et al. Among authors: ebihara h. J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S129-37. doi: 10.1093/infdis/jiu681. Epub 2015 Mar 24. J Infect Dis. 2015. PMID: 25810440 Free PMC article.

10

Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome.

Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. Luthra P, et al. Among authors: ebihara h. Cell Host Microbe. 2013 Jul 17;14(1):74-84. doi: 10.1016/j.chom.2013.06.010. Cell Host Microbe. 2013. PMID: 23870315 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page